March 12, 2021
Another special purpose acquisition company (SPAC) focused on longevity and rejuvenation biotechnology has appeared recently, and with the addition of research rockstars David Sinclair and Peter Attia, it could mean a bright future for healthy longevity. We recently talked about how SPACs could transform the longevity research industry in Humacyte in Deal to Develop Prosthetic...